Stay updated on ADVOCATE: Avacopan Clinical Trial
Sign up to get notified when there's something new on the ADVOCATE: Avacopan Clinical Trial page.

Latest updates to the ADVOCATE: Avacopan Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedLocations are now presented under a single consolidated 'Locations' section listing all states; previously there were separate state-specific location subsections. The HHS Vulnerability Disclosure link was removed and the page revision updated from v3.3.2 to v3.3.3.SummaryDifference1.0%

- Check15 days agoNo Change Detected
- Check30 days agoChange DetectedAdded a note that publications are automatically filled from PubMed and included the Revision: v3.3.2 tag; replaced the previous PubMed description and removed Revision: v3.2.0.SummaryDifference0.0%

- Check37 days agoChange DetectedThe government funding status notice was removed from the page. Core study details, contacts, and locations are unchanged.SummaryDifference0.1%

- Check59 days agoChange DetectedThe observed changes consist mainly of formatting adjustments and minor content updates on the study page, with no alterations to core details such as eligibility criteria, primary outcomes, enrollment, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check73 days agoChange DetectedAdded a new reference to a study on avacopan for ANCA-associated vasculitis (ADVOCATE Study Group) with full citation and DOI.SummaryDifference0.8%

- Check80 days agoChange DetectedSignificant update: new operating-status notice and version bump to v3.2.0; previous v3.1.0 reference removed.SummaryDifference2%

Stay in the know with updates to ADVOCATE: Avacopan Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ADVOCATE: Avacopan Clinical Trial page.